Joinn Laboratories(China)Co.,Ltd.

HKSE 6127.HK

Joinn Laboratories(China)Co.,Ltd. Total Non-Current Liabilities for the year ending December 31, 2023: USD 39.26 M

Joinn Laboratories(China)Co.,Ltd. Total Non-Current Liabilities is USD 39.26 M for the year ending December 31, 2023, a -17.67% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • Joinn Laboratories(China)Co.,Ltd. Total Non-Current Liabilities for the year ending December 31, 2022 was USD 47.69 M, a 69.85% change year over year.
  • Joinn Laboratories(China)Co.,Ltd. Total Non-Current Liabilities for the year ending December 31, 2021 was USD 28.08 M, a 48.26% change year over year.
  • Joinn Laboratories(China)Co.,Ltd. Total Non-Current Liabilities for the year ending December 31, 2020 was USD 18.94 M, a 22.39% change year over year.
  • Joinn Laboratories(China)Co.,Ltd. Total Non-Current Liabilities for the year ending December 31, 2019 was USD 15.47 M, a 31.87% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
SV Wall Street
HKSE: 6127.HK

Joinn Laboratories(China)Co.,Ltd.

CEO Dr. Yuxia Feng M.D.
IPO Date Feb. 26, 2021
Location China
Headquarters A5 Rongjing East Street
Employees 2,510
Sector Health Care
Industries
Description

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers investment management and cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.

Similar companies

9995.HK

RemeGen Co., Ltd.

USD 1.76

1.76%

3759.HK

Pharmaron Beijing Co., Ltd.

USD 1.84

0.83%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 3.70

-0.36%

StockViz Staff

January 31, 2025

Any question? Send us an email